Old Web
English
Sign In
Acemap
>
authorDetail
>
Chetan S Karyekar
Chetan S Karyekar
Janssen Pharmaceutica
Psoriatic arthritis
Medicine
Internal medicine
Guselkumab
Placebo
3
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Work absenteeism and disability associated with psoriasis and psoriatic arthritis in the USA-a retrospective study of claims data from 2009 TO 2020.
2021
Clinical Rheumatology
Ana-Maria Orbai
Soumya M. Reddy
N Dennis
R. Villacorta
S Peterson
L. Mesana
Soumya D. Chakravarty
Iris Lin
Chetan S Karyekar
Y Wang
M Pacou
Jessica A. Walsh
Show All
Source
Cite
Save
Citations (0)
Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies
2021
Philip J. Mease
Philip S. Helliwell
Dafna D. Gladman
Denis Poddubnyy
Xenofon Baraliakos
Soumya D. Chakravarty
A. Kollmeier
Elizabeth C. Hsia
Xie L. Xu
S. Sheng
Prasheen Agarwal
B. Zhou
Kristen Sweet
May Shawi
Chetan S Karyekar
Atul Deodhar
Désirée van der Heijde
Show All
Source
Cite
Save
Citations (5)
Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response-results from two phase 3 clinical trials of 1120 patients with active psoriatic arthritis.
2021
Arthritis Research & Therapy
Proton Rahman
Philip J. Mease
Philip S. Helliwell
Atul Deodhar
Laure Gossec
Arthur Kavanaugh
A. Kollmeier
Elizabeth C. Hsia
B. Zhou
Xiwu Lin
May Shawi
Chetan S Karyekar
Chenglong Han
Show All
Source
Cite
Save
Citations (0)
1
map